Agency News

Business News | Dr Yukata Niihara Felicitated by Minister of State, Arun Halder for Developing FDA- Approved Drug ENDARI to Fight SCD

Get latest articles and stories on Business at LatestLY. Dr Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Minister of State, Arun Halder. This felicitation came as a recognition of Dr Yuktaka Niihara's work - the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Business News | Dr Yukata Niihara Felicitated by Minister of State, Arun Halder for Developing FDA- Approved Drug ENDARI to Fight SCD

New Delhi [India], December 16 (ANI/SRV): Dr Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Minister of State, Arun Halder. This felicitation came as a recognition of Dr Yuktaka Niihara's work - the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Also Read | Morocco Was Rewarded by FIFA with Hosting Rights for the Next Club World Cup in February – Latest Tweet by Bloomberg.

Dr Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

This story has been provided by SRV. ANI will not be responsible in any way for the content in this article. (ANI/SRV)

Also Read | Union Minister Anurag Thakur, Meenakshi Lekhi Slam Pakistan Foreign Minister Bilawal Bhutto for Remarks Against PM Narendra Modi.

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)